Patents-Review.com
🔗 Permalink
Assignee profile:

InteRNA Technologies B.V.

City:

Nijmegen

Country:

Netherlands

Published Applications:

14

Last publication date:

2023-05-04

Patent Grants:

10

Last grant date:

2022-11-15

Top Inventors for applications by InteRNA Technologies B.V.

These are the the leading inventors for applications assigned to InteRNA Technologies B.V.:

Recent patent applications by InteRNA Technologies B.V.

InteRNA Technologies B.V. based in Nijmegen, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-05-04
US20230136088A1
Chemistry; metallurgy

miRNA-193a for Promoting Immunogenic Cell Death

 #2 | 2022-09-01
US20220275368A1
Chemistry; metallurgy

NEW TREATMENTS INVOLVING MIRNA-193A

 #3 | 2021-10-14 ✅ Patent 11,497,762 granted on 2022-11-15
US20210315917A9
Human necessities

MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation

 #4 | 2021-02-11
US20210038732A1
Human necessities

ANTICANCER MICRORNA AND LIPID FORMULATIONS THEREOF

 #5 | 2020-11-12 ✅ Patent 11,497,762 granted on 2022-11-15
US20200352978A1
Human necessities

MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation

 #6 | 2017-10-26 ✅ Patent 10,583,149 granted on 2020-03-10
US20170304348A1
Human necessities

MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway

 #7 | 2017-05-11
US20170130277A1
Chemistry; metallurgy

BIOMARKER FOR COLORECTAL CANCER

 #8 | 2016-11-17 ✅ Patent 10,023,868 granted on 2018-07-17
US20160333353A1
Chemistry; metallurgy

MiRNA for treating diseases and conditions associated with neo-angiogenesis

 #9 | 2016-01-21 ✅ Patent 9,944,932 granted on 2018-04-17
US20160017338A1
Chemistry; metallurgy

MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT

 #10 | 2015-10-22 ✅ Patent 10,201,556 granted on 2019-02-12
US20150297626A1
Human necessities

Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway

 #11 | 2015-08-13 ✅ Patent 10,174,314 granted on 2019-01-08
US20150225716A1
Chemistry; metallurgy

MiRNA for treating head and neck cancer

 #12 | 2014-01-02 ✅ Patent 9,441,222 granted on 2016-09-13
US20140005251A1
Chemistry; metallurgy

MiRNA for treating diseases and conditions associated with neo-angiogenesis

 #13 | 2013-05-02 ✅ Patent 9,682,095 granted on 2017-06-20
US20130109741A1
Human necessities

MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway

 #14 | 2013-03-21 ✅ Patent 9,161,947 granted on 2015-10-20
US20130072545A1
Human necessities

MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT

Also check out INTERNA TECHNOLOGIES B.V.'s (Nijmegen, Netherlands) applicant profile with 9 patent applications submitted.

AssigneeID:

14997 ⎘